Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Walgreens Stock Drops on News of DOJ Lawsuit Alleging Pharmacy Filled Millions of Prescriptions Without Legitimate Medical Purpose - Kehoe Law Firm, P.C. Investigating - WBA

WBA

PHILADELPHIA, PA / ACCESS Newswire / January 18, 2025 / Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ:WBA).

WALGREENS INVESTORS WITH FINANCIAL LOSSES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE, NO OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

Investors of Walgreens should be aware that the U.S. Department of Justice ("DOJ") has filed a civil complaint in federal court alleging that Walgreens Boots Alliance, Walgreen Co. and various subsidiaries dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act ("CSA") and then sought reimbursement for many of these prescriptions from various federal health care programs in violation the False Claims Act ("FCA").

According to the complaint, ". . . from approximately August 2012 through the present, Walgreens knowingly filled millions of prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice. Among the millions of unlawful prescriptions that Walgreens allegedly filled were prescriptions for dangerous and excessive quantities of opioids, prescriptions for early refills of opioids and prescriptions for the especially dangerous and abused combination of drugs known as the 'trinity,' which is made up of an opioid, a benzodiazepine and a muscle relaxant."

On this news, the stock price of Walgreens dropped more than 5% after the stock market closed on January 17, 2025.

WALGREENS SHAREHOLDERS INTERESTED IN LEARNING MORE ABOUT THE SECURITIES CLASS ACTION INVESTIGATION CAN ALSO EMAIL INFO@KEHOELAWFIRM.COM OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, JKEHOE@KEHOELAWFIRM.COM, OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM.

Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm, P.C. have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

SOURCE: Kehoe Law Firm, P.C.



View the original press release on ACCESS Newswire